-
Most Recent
Search Results
240 results for BIOF
IBIO Stock Is a Unique and Worthy Biotech Bet
IBIO stock looks like a worthy wager on exciting plant-based solutions. Here’s what prospective investors need to consider before buying.
iBio Is a Wishful Thinkers Coronavirus Vaccine Bet
IBIO stock isn’t the coronavirus vaccine bet investors should pursue, with its candidates in pre-clinical stages showing minimal promise.
Without a Partner, iBio’s Gains Are Just a Fantasy
iBio is behind others in developing a Covid-19 vaccine and it doesn’t have a FastPharming partner. There’s diminishing value to IBIO stock.
BioNano Genomics Is About the Future, Not the Present
BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities.
A Dice-Roll on iBio Stock Is Much Less Appealing Now
Since hitting $1.70 on Aug. 21, IBIO stock has gone sideways. With little on the news front over the past seven weeks, it’s easy to…
Looking for a Pot Stock With a Wide Moat and a Dividend? Try IIPR
Very few marijuana stocks pay dividends. Since it’s structured as an REIT, IIPR is an exception to the rule — but a risky one.
Biotech Innovator IBIO Is Down, but Not Out for the Long Term
Biotech innovator IBIO stock has been tossed around based on iBio’s COVID-19 vaccine progress, but its FastPharma tech is the long-term play.
Coronavirus-Fighting Tech Makes iBio Stock an Interesting Play
After years trading with penny status, IBIO stock needs more than just a coronavirus vaccine to sustain its surge.
Hold iBio Shares as Q2 Highlights Strong Product Catalog
With iBio making key executive-level appointments and recording excellent fiscal stats, IBIO stock’s value proposition is hard to ignore.
Early Shareholders Can Win If iBio Gets a Vaccine Contract
As companies race to develop a Covid-19 vaccine, IBIO stock investors are likely paying too much for a potential manufacturing contract.
First to COVID-19 Vaccine or Not, iBio Is a Smart Investment
IBIO stock has been hit hard by its apparent failure to produce the first COVID-19 vaccine, but that’s a simplistic view of iBio’s prospects.
Provention Bio (PRVB) Stock Falls Despite FDA Approval
Provention Bio is celebrating a milestone medical moment. Yet, PRVB stock is falling because an important drug may be overpriced.
Bank of America (BAC) – 5 Reasons to Buy this Stock
Bank of America (BAC) is one of the biggest financial stocks on Wall Street. And though financial regulatory reform is the order of the day,…
Bio-Rad Shares Make the Grade Over Alere
The medical testing sector is booming, but Bio-Rad has shown the ability to consistently generate profit.
Should You Buy Bio-Path Stock After 5-Fold Gain? 3 Pros, 3 Cons
BPTH stock is easily one of 2019’s top performers, but you’ve got to look at the whole Bio-Path story before jumping aboard.
You’ve Been Warned! 3 Meme Stocks to Buy Now or Regret Forever
These are the meme stocks to buy for stellar returns as they represent companies poised for healthy growth and cash flow upside.
10 – 10 of 240 results
